12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Prophylactic HCV vaccine: Phase I/II started

Okairos began a double-blind, placebo-controlled Phase I/II to evaluate Okairos' prophylactic HCV vaccine in about 350 patients.

Okairos AG,...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >